12-4810687-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_002235.5(KCNA6):c.646C>T(p.Pro216Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000316 in 1,614,104 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_002235.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNA6 | NM_002235.5 | c.646C>T | p.Pro216Ser | missense_variant | 1/1 | ENST00000280684.4 | NP_002226.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNA6 | ENST00000280684.4 | c.646C>T | p.Pro216Ser | missense_variant | 1/1 | 6 | NM_002235.5 | ENSP00000280684.3 | ||
GALNT8 | ENST00000542998.5 | c.310-40051C>T | intron_variant | 3 | ENSP00000440383.1 | |||||
ENSG00000256988 | ENST00000662877.1 | n.409+2869G>A | intron_variant | |||||||
ENSG00000256988 | ENST00000664363.1 | n.1626+2869G>A | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152134Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000398 AC: 10AN: 251100Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135682
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1461852Hom.: 0 Cov.: 33 AF XY: 0.0000179 AC XY: 13AN XY: 727226
GnomAD4 genome AF: 0.000138 AC: 21AN: 152252Hom.: 0 Cov.: 33 AF XY: 0.000134 AC XY: 10AN XY: 74430
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 10, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at